Journal of Multiple Sclerosis and Neuroimmunology

Search

Page Path

HOME
Search

Case Report

리툭시맙 치료로 호전된 재발 중추신경계원발혈관염 1예: 김태영, 김용진, 김민, 전재현, 박현미, 신동훈, 양지원; J Mult Scler Neuroimmunol. 2022;13(2):30-34. Published online December 31, 2022; PDF

Volume 15, No. 1

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

6,016	Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
2,667	Rituximab Treatment for Neuroimmunologic Disorders
2,373	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
2,335	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
2,216	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review

Cited By
2

Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: icandr@cau.ac.kr

Copyright © 2024 by Korean Society of Neuroimmunology.